PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
21.05.24
/
50%
€35.00
Target price
21.05.25
€29.48
Performance (%)
-14.86%
Price
22.07.24
€29.80
Summary
This prediction is currently active. The price of PTC Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.86%. This prediction currently runs until 21.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 0.667% | 0.667% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.60
28.05.24
28.05.24
€29.42
28.05.25
28.05.25
-9.52%
22.07.24
22.07.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€20.61
18.09.24
18.09.24
33.33%
22.07.24
22.07.24